CMND
Clearmind Medicine·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CMND Filings
Filing Date
Form Description
Form Type
2025-12-03
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-03 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-03
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-03 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-02 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-01
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-01 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-01
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-01 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-28
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-28 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-28
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-28 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-26
Form F-1 - Registration statement for certain foreign private issuers
2025-11-26 ·
Form F-1 - Registration statement for certain foreign private issuers
2025-11-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-26 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-26
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-26 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
